Utah Pharmacy Accused of Purchasing Mislabeled Hydroxychloroquine Product from China

Utah Pharmacy Accused of Purchasing Mislabel Hydroxychloroquine Product from China

A pharmacy based in Draper, Utah, finds itself in trouble with the law as they recently imported from China 50 kilos of chloroquine and over 500 kilos of hydroxychloroquine, the anti-malaria drug once considered a treatment for COVID-19. The drug is still being used in clinical trials targeting COVID-19, such as the prominent African clinical trial known as ANTICOV. KUTV’s McKenzie Stauffer recently reported that Daniel Richards, CEO of Meds in Motion, received the shipment from China but that the firm wasn’t “…duly registered as a drug manufacturer with [the] Food and Drug Administration.”  Apparently, according to local court documents, the drug product was falsely labeled as “Boswellia Serrata Extract” also known as Frankincense, an herbal treatment used in the treatment of arthritis, inflammation and other ailments. The CEO was apparently charged in the U.S. District Court in Salt Lake City on misdemeanor charges for receiving “misbranded drugs in interstate commerce,” reported Ms. Stauffer. Hydroxychloroquine represented significant business as in March, before the FDA emergency use authorization was revoked, as Utah paid $800,000 to Meds in Motion for hydroxychloroquine to t...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee